Anest. intenziv. Med. 2018;29(1):14-22

Perioperative myocardial injury: Our fault or inflammation?Anaesthesiology - Review articles

K. Skarvan
Departement Anästhesie und Intensivmedizin, Universitätssspital Basel, Švýcarsko

In approximately one in ten patients undergoing major non-cardiac surgery, abnormal increases in plasma levels of high sensitivity cardiac troponin occur during the first postoperative days, suggesting postoperative myocardial injury. Most of these patients have no signs or symptoms of myocardial ischaemia or infarction. Nonetheless, they are at increased risk of both 30-day and long-term all-cause mortality as well as higher incidence of major cardiovascular adverse events, comparable to type 2 postoperative myocardial infarction. The myocardial injury is deemed to result from critical imbalance of myocardial O2 demand and supply. The pathophysiology, clinical implications and prevention of this condition are reviewed, and an alternative interpretation of the mechanisms causing cardiomyocyte necrosis - inflammation - is presented.

Keywords: high sensitivity cardiac troponin; non-cardiac surgery; myocardial injury; ischaemia; mortality; adverse events; inflammation; statins

Received: August 29, 2017; Accepted: January 12, 2018; Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skarvan K. Perioperative myocardial injury: Our fault or inflammation? Anest. intenziv. Med. 2018;29(1):14-22.
Download citation

References

  1. Skalická H, Moťovská Z, Toušek F. Summary of the 2014 ESC guidelines on non-cardiac surgery: cardiovascular assessment and management. Prepared by the Czech Society of cardiology. Cor et Vasa. 2015;57:e190-e213. Go to original source...
  2. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation. 2009; 119:2936-2944. Go to original source... Go to PubMed...
  3. Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154:523-528. Go to original source... Go to PubMed...
  4. van Waes JA., Nathoen HM, de Graaff JC, Kemperman H, de Borst GJ, Peelen LM, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation. 2013;127:2264-2271. Go to original source... Go to PubMed...
  5. van Waes JA, Grobben RB, Nathoe HM, Kemperman H, de Borst GJ, Peelen LM, et al. One-Year Mortality, Causes of Death, and Cardiac Interventions in Patients with Postoperative Myocardial Injury. Anesth Analg. 2016;123:29-37. Go to original source... Go to PubMed...
  6. Smilowitz NR, Gupta N, Guo Y, Berger J, Bangalore S. Perioperative myocardial infarction associated with non-cardiac surgery. Eur Heart J. 2017;38:2409-2417. Go to original source... Go to PubMed...
  7. Smilowitz NR, Gupta N, Ramakrishna NR, Gupta N, Guo Y, Berger JS, Bangalore S. Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery. JAMA Cardiol. 2017;2:181-187. Go to original source... Go to PubMed...
  8. Parashar A, Agarwal S, Krishnaswamy A, Sud K, Poddar KL, Bassi M, et al. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes. J Am Coll Cardiol. 2016;68:329-338. Go to original source... Go to PubMed...
  9. Dauerman HL. The Expanding Universe of Perioperative Myocardial Infarction. J Am Coll Cardiol. 2016;68:339-342. Go to original source... Go to PubMed...
  10. Landesberg G, Mosseri M, Zahger D, Wolf Y, Perouansky M, Anner H, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol. 2001;37:1839-1845. Go to original source... Go to PubMed...
  11. Filipovic M, Jeger R, Probst C, Girard T, Pfisterer M, Gurke L, et al. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. J Am Coll Cardiol. 2003;42:1767-1776. Go to original source... Go to PubMed...
  12. Ekeloef S, Alamili M, Devereaux PJ, Gogenur I. Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis. Br J Anaesth. 2016;117:559-568. Go to original source... Go to PubMed...
  13. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, JaffeH AS, Katus A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254-261. Go to original source... Go to PubMed...
  14. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Research. 2017;113:1708-1718. Go to original source... Go to PubMed...
  15. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, et al. Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol. 2017;70:996-1012. Go to original source... Go to PubMed...
  16. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57:2406-2408. Go to original source... Go to PubMed...
  17. Eggers KM, Venge P, P. Lindahl B., Lind L. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol. 2013.61:1906-1913. Go to original source... Go to PubMed...
  18. Willeit P, Welsh P, Evans JDW, Tschiderer L, Boachie C, Jukema JW, et al. High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants. J Am Coll Cardiol. 2017;70:558-568. Go to original source... Go to PubMed...
  19. Botto F, Alonso-Coello P, Chan MT, Villar JC, Xavier D, Srinathan S, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120:564-578. Go to original source... Go to PubMed...
  20. Maile MD, Jewell ES, Engoren MC. Timing of Preoperative Troponin Elevations and Postoperative Mortality After Noncardiac Surgery. Anesth Analg. 2016;123:135-140. Go to original source... Go to PubMed...
  21. Noordzij PG, van Geffen O, Dijkstra IM, Boerma D, Meinders AJ, Rettig TC, et al. High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. Br J Anaesth. 2015;114:909-918. Go to original source... Go to PubMed...
  22. Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, et al. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA. 2017;317:1642-1651. Go to original source... Go to PubMed...
  23. Reed GW, Horr S, Young L, Clevenger J, Malik U, Ellis SG, et al. Associations beteen cardiac troponin, mechanism of myocardial injury, and long-term mortality after noncardiac vascular surgery. J Am Heart Assoc. 2017;6:e005672. Go to original source... Go to PubMed...
  24. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551-2567. Go to original source... Go to PubMed...
  25. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. Go to original source... Go to PubMed...
  26. Duvall WL, Sealove B, Pungoti C, Katz D, Moreno P, Kim M. Angiographic investigation of the pathophysiology of perioperative myocardial infarction. Catheter Cardiovasc Interv. 2012;80:768-776. Go to original source... Go to PubMed...
  27. Hanson I, Kahn J, Dixon S, Goldstein J. Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction. Catheter Cardiovasc Interv. 2013;82: 622-628. Go to original source... Go to PubMed...
  28. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57:37-44. Go to original source... Go to PubMed...
  29. Gualandro DM, Campos CA, Calderaro D, Yu PC, Marques AC, Pastana AF, et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis. 2012;222:191-195. Go to original source... Go to PubMed...
  30. Smilowitz NR, Weiss MC, Mauricio R, Mahajan AM, Dugan KE, Devanabanda A, et al. Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. Int J Cardiol. 2016;218:196-201. Go to original source... Go to PubMed...
  31. Cediel G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, Boque C, Bardaji A. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart. 2016;103:616-622. Go to original source... Go to PubMed...
  32. Smilowitz NR, Naoulou B, Sedlis SP. Diagnosis and management of type II myocardial infarction: increased demand for a limited supply of evidence. Curr Atheroscler Rep. 2015;17:478, doi:10.1002//311883-0140478-1. Go to original source... Go to PubMed...
  33. Baron JM, Lewandrowski EL, Januzzi JL, Bajwa EK, Thompson BT, Lewandrowski KB. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. Am J Clin Pathol. 2014;141:488-493. Go to original source... Go to PubMed...
  34. Smilowitz NR, Gupta N, Guo Y, Bangalore B. Comparison of Outcomes of Patients With Sepsis With Versus Without Acute Myocardial Infarction and Comparison of Invasive Versus Noninvasive Management of the Patients With Infarction. Am J Cardiol. 2016;117:1065-1071. Go to original source... Go to PubMed...
  35. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. 2002;105:1135-1143. Go to original source... Go to PubMed...
  36. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 2014;114:1867-1879. Go to original source... Go to PubMed...
  37. Michail M, Serruys PW, Stettler R, Crake T, Torii R, Tenekecioglu E, et al. Intravascular multimodality imaging: feasibility and role in the evaluation of coronary plaque pathology. Eur Heart J Cardiovasc Imaging. 2017;18:613-620. Go to original source... Go to PubMed...
  38. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317-2322. Go to original source... Go to PubMed...
  39. Crea F, Libby P. Acute coronary syndroms. The way forward from mechanisms to precision treatment. Circulation. 2017;136:1155-1166. Go to original source... Go to PubMed...
  40. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487:325-329. Go to original source... Go to PubMed...
  41. Joshi NV, Toor I, Shah AS, Carruthers K, Vesey AT, Alam SR, et al. Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction. J Am Heart Assoc. 2015;4:e001956. Go to original source... Go to PubMed...
  42. Han Y, Jing J, Tu S, Tian F, Xue H, Chen W, et al. ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis. Int J Cardiovasc Imaging. 2014;30:253-261. Go to original source... Go to PubMed...
  43. Bergh C, Fall K, Udumyan R, Sjöqvist H, Frobert O, Montgomery S. Severe infections and subsequent delayed cardiovascular disease. European journal of preventive Cardiology. 2017;0:1-9. Go to original source... Go to PubMed...
  44. Sheth T, Chan M, Butler C, Chow B, Tandon V, Nagele P, Mitha A, Mrkobrada M., et al. BMJ. 2015;350:h1907. Go to original source... Go to PubMed...
  45. Grobben RB, van Waes JAR, Leiner T, Peelen LM, de Borst GJ, Vogely HC, Grobbee DE, Doevendans PA, van Klei WA, Nathoe HM, on behalf of the CHASE Investigators. Unexpected Cardiac Computed Tomography Findings in Patients With Postoperative Myocardial Injury. Anesth Analg. 2017 Nov 1. doi: 10.1213/ANE.0000000000002580. [Epub ahead of print]. Go to original source... Go to PubMed...
  46. Ford I, Shah AS, Zhang R, McAllister DA, Strachan FE, Caslake M, et al. High sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. 2016;68:2719-2728. Go to original source... Go to PubMed...
  47. Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, et al. Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Circ Cardiovasc Imaging. 2016;9:e004195. Go to original source... Go to PubMed...
  48. Berwanger O, Le Manach Y, Suzumura EA, Biccard B, Srinathan SK, Szczeklik W, et al. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J. 2016;37:p177-185. Go to original source... Go to PubMed...
  49. Ridker PM, Everett BM, Thuren T, McFadyen SG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119-1131. Go to original source... Go to PubMed...
  50. Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017;33:17-32. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.